Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Tislelizumab Combined With Anlotinib and Chemotherapy (XELOX) in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (TALENT) [Phase 1, Phase 2]
A Phase 1/2 study (TALENT) evaluated tislelizumab with anlotinib and XELOX chemotherapy for advanced gastric or gastroesophageal junction ad…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Combination COMBO Endoscopy Oropharyngeal Airway With High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese Patients [Phase 2]
A Phase 2 clinical trial evaluating the combination of COMBO endoscopy oropharyngeal airway with high-flow nasal cannula oxygenation during …
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study. [Phase 2]
This Phase 2 trial assesses the feasibility of an early palliative care intervention for patients with metastatic cancer. The study has comp…
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer [Phase 1]
Phase 1 clinical trial evaluating PD-1-M1-NK cells for advanced gastric or colorectal cancer (not yet recruiting).
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer [Phase 2]
A Phase 2 trial of perioperative chemoimmunotherapy with or without preoperative chemoradiation for locally advanced gastric cancer was term…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study of CDX-585 in Patients With Advanced Malignancies [Phase 1]
Phase 1 trial update showing completed enrollment and results for CDX-585 in patients with advanced solid tumors, including non-small cell l…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer [Phase 2]
Phase 2 study evaluating efficacy and safety of multiple doses of IMAB362 in patients with advanced gastroesophageal cancer. The trial statu…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors [Phase 2]
Phase II clinical trial of PRL3-ZUMAB in advanced solid tumors is currently recruiting, with planned investigations in gastric cancer and he…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Assessment of Robotic Versus Laparoscopic Gastrectomy for GC Patients With Intraoperative Technical Complexity
A completed clinical trial comparing robotic versus laparoscopic gastrectomy for gastric cancer patients with intraoperative technical compl…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: TAC T-cells for the Treatment of HER2-positive Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating TAC T-cells for HER2-positive solid tumors, including HER2-positive gastric cancer and metastatic HER2-positive g…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Efficacy and Safety of Neoadjuvant Nivolumab Plus SOX Versus Nivolumab Plus FLOT in Patients With HER2-negative Gastric and Gastroesophageal Junction Adenocarcinoma
A completed neoadjuvant trial comparing nivolumab plus SOX versus nivolumab plus FLOT in HER2-negative gastric and gastroesophageal junction…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer
This clinical trial evaluated conversion surgery after targeted therapy or immunotherapy for stage IV gastric cancer; the study status is co…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Nasal Mask Kit in Gastrointestinal Endoscopy [NA]
A completed clinical trial evaluating a nasal mask kit used during gastrointestinal endoscopy, with indications including gastric cancer, co…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery [Phase 1, Phase 2]
This update covers a Phase 1/2 trial of olaparib plus ramucirumab in patients with metastatic or locally recurrent gastric or gastroesophage…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of electroacupuncture, paclitaxel protein-bound, and a PD-1 antibody as second-line ther…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore [Phase 2]
Phase 2 clinical trial assessing first-line treatment with lenvatinib plus tislelizumab and CapeOX for advanced gastric/gastroesophageal jun…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy [Phase 1, Phase 2]
This update reports results from a Phase 1/2 study of NGM120 in combination therapy for patients with advanced solid tumors, including pancr…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]
Pfizer's Phase 1 study of PF-06940434 in advanced or metastatic solid tumors has been terminated. The trial enrolled several solid tumor typ…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: COMBO Endoscopy Oropharyngeal Airway in Sedated Gastrointestinal Endoscopy for Obese Patients [Phase 2]
Phase 2 trial of the COMBO Endoscopy Oropharyngeal Airway used during sedated gastrointestinal endoscopy in obese patients has completed rec…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors [Phase 1]
Phase 1 dose-escalation study of MNPR-101-PCTA-177Lu in solid tumors is currently recruiting across multiple cancer indications.
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer
A completed clinical trial evaluating PET imaging with the radiotracer 18F-BMS-986229 in patients with cancers of the esophagus, stomach, or…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study [NA]
The RT-CAMSS study, a real-time monitoring trial of chemotherapy side-effects in gastrointestinal cancers, has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Totally Laparoscopic Distal Gastrectomy VS Pylorus-Preserving Gastrectomy for Early Gastric Cancer in the Middle Stomach
This clinical trial update reports the completion of a study comparing totally laparoscopic distal gastrectomy with pylorus-preserving gastr…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating APR-246 in combination with pembrolizumab in solid tumors has completed enrollment with results posted…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) [Phase 2]
Phase 2 study evaluating IMU-131 (HER-Vaxx) with chemotherapy or pembrolizumab in metastatic HER2-overexpressing gastric cancer; the trial w…